Dermatology and the Fda, an Issue of Dermatologic Clinics: Volume 39-3

In this issue of Dermatologic Clinics, guest editor Dr. Markham C. Luke brings his considerable expertise to the topic of Food and Drug Administration's Role in Dermatology. This special issue focuses on the field of dermatology's relationship to the FDA. Written entirely by experts within the Food and Drug Administration, it provides important perspectives on many topics of interest, including post-market assessment for drugs and biologics for dermatology; FDA research in dermatopharmacology; endpoints used to assess the effectiveness of drugs in dermatology; the future of dermatological drugs; and more.

Contains 13 relevant, practice-oriented topics including aiding access to dermatological drugs through generic drug development; dermatology drugs for children; regulation of medical devices for dermatology (lasers and energy delivery devices/fillers and wound healing); regulation of cosmetics and personal care products; the role of pharmacokinetics in evaluation of dermatological drugs; and more.

Provides in-depth clinical reviews on the FDA's role in dermatology, offering actionable insights for clinical practice.

Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

• Format: Hardcover
• Language: English
• ISBN: 0323793312
• ISBN13: 9780323793315
• Release Date: February 2022
• Publisher: Elsevier
• Length: 240 Pages